Key Highlights
•
A new study shows that a common diabetes drug, metformin, can reduce the risk of developing long COVID by about 40% in people with mild to moderate COVID-19. This finding is important because it offers a widely available and inexpensive treatment to prevent a condition that affects millions worldwide.
Source →
•
Researchers have discovered a new antibody that can neutralize nearly all known variants of the SARS-CoV-2 virus, including the highly mutated Omicron sub-lineages. This development is a major step forward because it could lead to a single, universal vaccine or therapy that protects against future variants without needing constant updates.
Source →
•
A comprehensive analysis of wastewater from major cities reveals that antibiotic-resistant bacteria are spreading much faster in low-income communities than in wealthier areas. The significance of this finding is that it highlights a hidden environmental justice issue, where poverty and poor sanitation may be driving the rise of superbugs that threaten everyone.
Source →
•
Scientists have finally cracked the structure of a key protein used by the malaria parasite to invade human red blood cells, solving a 20-year-old mystery. This breakthrough opens the door for designing a highly effective vaccine that could prevent the parasite from ever entering cells, potentially saving hundreds of thousands of lives each year.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
